| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 8e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.05 |